NCT03934710View on ClinicalTrials.gov

Mood Effects of Serotonin Agonists Extended

PHASE1CompletedINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

April 20, 2019

Primary Completion Date

June 7, 2021

Study Completion Date

June 7, 2021

Conditions
Healthy
Interventions
DRUG

Placebo

Drug will be administered in solution form

DRUG

Serotonin agonist - 13ug

13ug lysergic acid diethylamide

DRUG

Serotonin agonist - 26ug

26ug lysergic acid diethylamide

Trial Locations (1)

60637

Matthew Bona, Chicago

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

University of Chicago

OTHER

NCT03934710 - Mood Effects of Serotonin Agonists Extended | Biotech Hunter | Biotech Hunter